Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ella F Jones

Showing results (21-30 of 38) with videos related to

Pageof 4
Sort By:
Tomography (Ann Arbor, Mich.)|June 18, 2020
Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant TherapyAlex Anh-Tu Nguyen, Vignesh A Arasu, Fredrik Strand, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer TrialNatsuko Onishi, Wen Li, Jessica Gibbs, et al.
NPJ Breast Cancer|April 25, 2019
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiolElla F Jones, Kimberly M Ray, Wen Li, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 27, 2019
Additive value of diffusion-weighted MRI in the I-SPY 2 TRIALWen Li, David C Newitt, Lisa J Wilmes, et al.
Journal of Digital Imaging|April 22, 2021
Mask-Guided Convolutional Neural Network for Breast Tumor Prognostic Outcome Prediction on 3D DCE-MR ImagesGengbo Liu, Debasis Mitra, Ella F Jones, et al.
Translational Oncology|April 29, 2014
Repeatability of quantitative MRI measurements in normal breast tissueSheye O Aliu, Ella F Jones, Ania Azziz, et al.
Journal of Medical Imaging (Bellingham, Wash.)|January 4, 2018
Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIALAdam Olshen, Denise Wolf, Ella F Jones, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast CancerWen Li, David C Newitt, Bo La Yun, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Clinical Trial Design and Development Work Group Within the Quantitative Imaging NetworkElla F Jones, John M Buatti, Hui-Kuo Shu, et al.
Academic Radiology|April 11, 2013
High-resolution diffusion-weighted imaging for monitoring breast cancer treatment responseLisa J Wilmes, Rebekah L McLaughlin, David C Newitt, et al.
Pageof 4

Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Tomography (Ann Arbor, Mich.)|June 18, 2020
Comparison of Segmentation Methods in Assessing Background Parenchymal Enhancement as a Biomarker for Response to Neoadjuvant TherapyAlex Anh-Tu Nguyen, Vignesh A Arasu, Fredrik Strand, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Impact of MRI Protocol Adherence on Prediction of Pathological Complete Response in the I-SPY 2 Neoadjuvant Breast Cancer TrialNatsuko Onishi, Wen Li, Jessica Gibbs, et al.
NPJ Breast Cancer|April 25, 2019
Initial experience of dedicated breast PET imaging of ER+ breast cancers using [F-18]fluoroestradiolElla F Jones, Kimberly M Ray, Wen Li, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 27, 2019
Additive value of diffusion-weighted MRI in the I-SPY 2 TRIALWen Li, David C Newitt, Lisa J Wilmes, et al.
Journal of Digital Imaging|April 22, 2021
Mask-Guided Convolutional Neural Network for Breast Tumor Prognostic Outcome Prediction on 3D DCE-MR ImagesGengbo Liu, Debasis Mitra, Ella F Jones, et al.
Translational Oncology|April 29, 2014
Repeatability of quantitative MRI measurements in normal breast tissueSheye O Aliu, Ella F Jones, Ania Azziz, et al.
Journal of Medical Imaging (Bellingham, Wash.)|January 4, 2018
Features of MRI stromal enhancement with neoadjuvant chemotherapy: a subgroup analysis of the ACRIN 6657/I-SPY TRIALAdam Olshen, Denise Wolf, Ella F Jones, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast CancerWen Li, David C Newitt, Bo La Yun, et al.
Tomography (Ann Arbor, Mich.)|June 18, 2020
Clinical Trial Design and Development Work Group Within the Quantitative Imaging NetworkElla F Jones, John M Buatti, Hui-Kuo Shu, et al.
Academic Radiology|April 11, 2013
High-resolution diffusion-weighted imaging for monitoring breast cancer treatment responseLisa J Wilmes, Rebekah L McLaughlin, David C Newitt, et al.
Pageof 4